As of Nov 2, 2026, LFST's PEG ratio of 0.25 reflects its valuation relative to its growth. This value reflects a P/E ratio of 94.71 measured against EPS growth of 380.0%.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 1.96 | 234.67 | 120% |
| 2024 | N/A | N/A | 70.6% |
| 2023 | N/A | N/A | 16.4% |
| 2022 | N/A | N/A | 41.9% |
| 2021 | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.2 | 76.5 | 380% |
| Mar 2026 | 0.54 | 91 | 170% |
| Dec 2025 | 1.96 | 234.67 | 120% |
| Sep 2025 | N/A | N/A | 88.5% |
| Jun 2025 | N/A | N/A | 87.8% |
| Mar 2025 | N/A | N/A | 79.2% |
| Dec 2024 | N/A | N/A | 70.6% |
| Sep 2024 | N/A | N/A | 50% |
| Jun 2024 | N/A | N/A | 10.9% |
| Mar 2024 | N/A | N/A | 7.7% |
| Dec 2023 | N/A | N/A | 16.4% |
| Sep 2023 | N/A | N/A | 35% |
| Jun 2023 | N/A | N/A | 55.8% |
| Mar 2023 | N/A | N/A | 51.4% |
| Dec 2022 | N/A | N/A | 41.9% |
With a PEG of 0.25, LFST is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.71, LifeStance Health Group's PEG is 65% lower.
Based on Nov 2, 2026 data, LFST carries a PEG ratio of 0.25.
Strong earnings growth relative to valuation produces LFST's low PEG ratio of 0.25.
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Nov 2, 2026, LifeStance Health Group has a P/E ratio of 94.71. Earnings grew at 380.0% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 0.25. PEG RATIO(0.25) = PE RATIO(94.71) / EPS GROWTH(380.0%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.